Dorothy J. Clarke - 01 Jan 2024 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
General Counsel, Director
Signature
/s/ Dorothy Clarke
Issuer symbol
ERNA
Transactions as of
01 Jan 2024
Net transactions value
$0
Form type
4
Filing time
03 Jan 2024, 17:01:31 UTC
Previous filing
13 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (right to buy) Award $0 +168,521 $0.000000 168,521 01 Jan 2024 Common Stock, par value $0.005 per share 168,521 $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continued service, 25% of the shares underlying the stock option will vest on the nine-month anniversary of the grant date, and the remaining shares underlying the stock option will vest in 39 substantially equal monthly installments thereafter.